Bioscrip Inc (BIOS) 2.83 $BIOS BioScrip (BIOS) in Focus:

New Post Public Reply Private Reply Replies (0) Message Board

Jun 12, 2016 at 6:00 AM

Bioscrip Inc (BIOS) 2.83 $BIOS

BioScrip (BIOS) in Focus: Stock Adds 8.4% in Session
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 7:00AM CDT
BioScrip , Inc. (BIOS) was a big mover last session, as the company's shares rose over 8% on the day.
LHCG: 42.75 (-0.78), BIOS: 2.83 (-0.10)

BioScrip (BIOS) Q1 Loss Wider than Expected, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:11AM CDT
BioScrip, Inc. (BIOS) reported net loss from continuing operations of 17 cents per share in the first quarter of 2016.
USPH: 59.40 (-0.25), AFAM: 42.11 (-0.81), BIOS: 2.83 (-0.10), HLS: 40.54 (-1.02)

BioScrip Reports First Quarter 2016 Financial Results
GlobeNewswire - Thu May 05, 3:30PM CDT
BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"

today announced financial results for the first quarter 2016. For the first quarter, the Company reported revenue from continuing operations of $238.5 million, net loss from continuing operations of ($11.9) million and diluted EPS of ($0.17) loss per share.
BIOS: 2.83 (-0.10)

BioScrip To Host 2016 First Quarter Results Call
GlobeNewswire - Mon Apr 18, 3:30PM CDT
BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will release its 2015 first quarter financial results on Thursday, May 5, 2016, after the close of the U.S. financial markets.
BIOS: 2.83 (-0.10)

BioScrip Announces Filing of Shelf Registration Statement to Replace Expiring Registration Statement
GlobeNewswire - Fri Apr 01, 11:06AM CDT
BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"

today announced that, in order to replace its expiring registration statement, it has filed to renew its current shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC). The registration statement is subject to review by the SEC.
BIOS: 2.83 (-0.10)

Bernstein Litowitz Berger & Grossmann LLP Announces Proposed Settlement of In Re BioScrip, Inc. Securities Litigation
PR Newswire - Thu Mar 24, 9:00AM CDT
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK
BIOS: 2.83 (-0.10)

BioScrip Posts Wider-than-Expected Q4 Loss, Margins Down
Zacks Equity Research - Zacks Investment Research - Thu Mar 03, 9:00AM CST
BioScrip (BIOS) posted a mixed fourth-quarter 2015 with the top line exceeding our estimate and the bottom line missing the same
BIOS: 2.83 (-0.10), VASC: 39.58 (-0.56), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)

BioScrip Reports Fourth Quarter 2015 Financial Results
GlobeNewswire - Wed Mar 02, 3:30PM CST
Q4 Consolidated Adjusted EBITDA of $9.0 Million
BIOS: 2.83 (-0.10)

BioScrip Soars on Progress in Financial Improvement Plan
Zacks Equity Research - Zacks Investment Research - Thu Jan 21, 12:40PM CST
BioScrip (BIOS) also successfully implemented its cost reduction programs, which are expected to reduce infusion field related costs by $5 million in 2016.
CAPR: 3.21 (-0.30), ABAX: 45.53 (-1.36), LMAT: 15.03 (-0.06), BIOS: 2.83 (-0.10)

BioScrip Provides Business Update on Implementation of Financial Improvement Plan and Progress to Enhance Shareholder Value
GlobeNewswire - Tue Jan 19, 5:50AM CST
Review of Strategic Alternatives Continues
BIOS: 2.83 (-0.10)

BioScrip: Infusion Services Offers Hope amid Margin Woes
Zacks Equity Research - Zacks Investment Research - Tue Dec 22, 1:50PM CST
On Dec 21, we issued an updated research report on BioScrip, Inc. (BIOS) ??? provider of home infusion and pharmacy benefit management (PBM) services.
ICUI: 107.33 (-0.80), INSY: 13.99 (-2.04), ABAX: 45.53 (-1.36), BIOS: 2.83 (-0.10)

Where Investors Are Going - New Reports on II-VI Inc., Performance Sports Group, BioScrip and Rapid7
ACCESSWIRE - Mon Dec 14, 6:50AM CST
NEW YORK, NY / ACCESSWIRE / December 14, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: II-VI Inc. (NASDAQ: IVII), Performance Sports Group Ltd (NYSE: PSG), BioScrip Inc. (NASDAQ: BIOS) and Rapid7 Inc. (NASDAQ: RPD). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
PSG: 3.15 (-0.02), RPD: 14.49 (-0.14), BIOS: 2.83 (-0.10), IIVI: 19.86 (-0.66)

Trading Ahead of Upcoming Developments - Research on Vivus, ReneSola, Consumer Portfolio Services and BioScrip
ACCESSWIRE - Mon Nov 23, 7:20AM CST
NEW YORK, NY / ACCESSWIRE / November 23, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Vivus Inc. (NASDAQ: VVUS), ReneSola Ltd. (NYSE: SOL), Consumer Portfolio Services Inc. (NASDAQ: CPSS) and BioScrip Inc. (NASDAQ: BIOS). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
SOL: 1.30 (-0.05), CPSS: 3.95 (-0.02), VVUS: 1.19 (-0.03), BIOS: 2.83 (-0.10)

BioScrip's Strategic Plans on Track, Margin Concerns Stay
Zacks Equity Research - Zacks Investment Research - Tue Nov 17, 1:30PM CST
On Nov 13, we issued an updated research report on Bioscrip, Inc. (BIOS) ??? provider of home infusion and pharmacy benefit management (PBM) services.
ICUI: 107.33 (-0.80), NXTM: 20.63 (-0.36), BIOS: 2.83 (-0.10), HRC: 50.10 (-1.12)

BioScrip Q3 Loss Wider than Expected; Strategic Plan in Focus
Zacks Equity Research - Zacks Investment Research - Thu Nov 05, 12:45PM CST
BioScrip, Inc. (BIOS) reported adjusted net loss from continuing operations of 19 cents per share in the third quarter of 2015.
SRDX: 23.19 (-0.11), BIOS: 2.83 (-0.10), HRC: 50.10 (-1.12)

BioScrip Reports Third Quarter 2015 Financial Results
BusinessWire - Wed Nov 04, 6:00AM CST
--Results Demonstrate Progress Against Financial Improvement Plan
BIOS: 2.83 (-0.10)

CVS Health Q3 Earnings Rise Y/Y, Revenues Beat; View Up
Zacks Equity Research - Zacks Investment Research - Fri Oct 30, 10:01AM CDT
CVS Health Corporation (CVS) reported third-quarter 2015 adjusted earnings per share (EPS) of $1.28, up 11.3% year over year.
DPLO: 33.51 (-0.67), TGT: 67.88 (+0.19), BIOS: 2.83 (-0.10), CVS: 96.67 (-0.32)

BioScrip To Host 2015 Third Quarter Results Call
PR Newswire - Wed Oct 21, 3:30PM CDT
BioScrip, Inc. (NASDAQ: BIOS) announced today that the Company will release its 2015 third quarter results on Wednesday, November 4, 2015, before the U.S. financial markets open.
BIOS: 2.83 (-0.10)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Burtch Works Joins Databricks: Fueling AI Success

Game-Changer for AI Talent Market First off, let me tell you, in this data-driven world, finding solid AI talent is like hitting the jackpot. Burtch Works teaming up with Databricks? That's like leaping into a goldmine fully prepared. We're talking about forward-deployed engineers and specialized AI talent coming straight to your door. Closing the Impossible Talent Gap...

YouFit's $10M Club Overhaul: Skyline's Fitness Bet

Fresh Faces and New Beginnings: YouFit's Big Bet They say if you're not evolving, you're dying. In the fitness world, staying static is asking to be left in the dust. YouFit Gyms just scored a $10 million-plus windfall from Skyline Investors, a California-based private equity outfit with an eye on transforming tired corners into fresh fitness hubs. This move signals big...

Fake Profiles Dominate Daters' Trust Issues Today

Trust Erosion in the Digital Dating Arena When it comes to modern dating, we're not talking hearts and flowers anymore; it's more like an elaborate game of detective work. A recent survey from Stud or Dud highlights the harsh reality that blind trust in digital dating profiles is about as outdated as sending a singing telegram. Almost half of the respondents pinned fake...

EBONY Celebrates Cultural Icons at 2026 Power 100 Event

Dazzling Night in Los Angeles Honors Black Excellence Step aside Oscars, last night was about powerful celebrations. EBONY threw one hell of a party with its Power 100 event at the Hollywood Palladium. This gathering wasn't just an awards ceremony—it was an explosion of culture, rhythm, and nods to a legacy that’s made waves for over 80 years. Now, what makes this...

Covalus Honors Veterans Day, Embraces Core Values

Veteran-Owned Covalus Celebrates Its Legacy Pride runs deep at Covalus this Veterans Day, as they stop to honor the backbone of their operation — the United States veterans who walk their halls and shape their ethos. It's not just about laying wreaths or giving speeches. It's about living principles that resonate with their military DNA: service, integrity, leadership,...

Cepheid Expands Diagnostic Potential with IVDR Approval

A Key Milestone for Cepheid Breathing new life into Europe's diagnostic landscape, Cepheid's Xpert Respiratory Panel just snagged the CE marking under the IVDR. This ain't just some technical checkbox; this test's got the goods to spot 13 respiratory pathogens from one measly swab. It's a hefty lineup—think Adenovirus, different flavors of flu, and even the sneaky...

Maternal Role in Type 1 Diabetes: A Non-Genetic Angle

Unveiling the Maternal Puzzle in Type 1 Diabetes So here's a stumper: how come kids of moms with type 1 diabetes dodge the disease more than kids of dads with it? Simple genes don't account for it, says a study from University of Colorado Anschutz. With nearly 7,000 kids in this research, you'd think they'd find a genetic smoking gun. Nope. It's pointing to something else...

FIU's PPRIM Device: A New Hope Against Preterm Births

Engineering a Leap in Prenatal Care Talk about flipping the script on prenatal diagnostics. A team from Florida International University (FIU) thinks they've got just the thing to spot early risks of preterm births with a device called PPRIM. It's the brainchild of some sharp minds, including FIU doctoral students Jenny Pei and Amanda Sanchez, and it's come out of FIU's...

Ebix Relaunches A.D.A.M. SmartCare Platform for Clinicians

Revolutionizing Patient Education with SmartCare When you're in the thick of things, juggling a half-dozen patients with different needs all in a day’s work, you want your tools to be as fast and straightforward as a greasy spoon diner breakfast—simple, satisfying, and utterly dependable. And Ebix is betting they've cooked up just the recipe for that with their...

Western Digital Faces Investigation Over Fiduciary Breaches

Ringside Seat to Western Digital's Legal Turbulence If there's one thing that'll make an investor's hair stand on end, it's the whisper of fiduciary breaches. Western Digital Corporation (NASDAQ:WDC) just took a hit from Levi & Korsinsky, LLP, who've launched a full-scale investigation into potential breaches of fiduciary duties by select officers and directors. When a...